These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6483638)

  • 21. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ; Cefali EA; Straughn AB
    Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theophylline absorption in young asthmatic children receiving sustained-release formulations.
    Haltom JR; Szefler SJ
    J Pediatr; 1985 Nov; 107(5):805-10. PubMed ID: 4056986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
    Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
    Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
    Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
    Uematsu T; Follath F; Vozeh S
    Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.
    Wagner JG
    Clin Pharmacokinet; 1985; 10(5):432-42. PubMed ID: 3899457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative bio-availability of theophylline whole and halved sustained-release tablets.
    Müller FO; Hundt HK; Luus HG; van Dyk M; Groenewoud G; van der Meer MJ; Steinijans VW
    S Afr Med J; 1987 Aug; 72(3):175-8. PubMed ID: 3299763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
    Leeds NH; Gal P; Purohit AA; Walter JB
    J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of a slow-release theophylline product.
    Hendeles L; Weinberger M
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):743-51. PubMed ID: 3534055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability of theophylline following a rectally administered concentrated aminophylline solution.
    Mason WD; Lanman RC; Amick EN; Arnold J; March L
    J Allergy Clin Immunol; 1980 Aug; 66(2):119-22. PubMed ID: 7400475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.
    Coulthard KP; Birkett DJ; Lines DR; Grgurinovich N; Grygiel JJ
    Eur J Clin Pharmacol; 1983; 25(5):667-72. PubMed ID: 6686557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and pharmacokinetic concerns of 24-hour dosing with theophylline.
    Weinberger M
    Ann Allergy; 1986 Jan; 56(1):2-12. PubMed ID: 3511775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New method for bioavailability assessment of slow-release preparations of theophylline.
    Kasuya Y; Ohno T; Kubota N; Takahashi H; Hirayama H
    J Pharmacokinet Biopharm; 1985 Dec; 13(6):571-87. PubMed ID: 3834072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-dependent kinetics of theophylline disposition in asthmatic children.
    Weinberger M; Ginchansky E
    J Pediatr; 1977 Nov; 91(5):820-4. PubMed ID: 909026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
    Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
    Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of theophylline elimination rate.
    Milavetz G; Vaughan LM; Weinberger MM
    Clin Pharmacol Ther; 1987 Apr; 41(4):388-91. PubMed ID: 3549119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans.
    Raz I; Bialer M; Salame K; Bar-On H
    Eur J Clin Pharmacol; 1984; 26(3):401-3. PubMed ID: 6734702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Food and fasting absorption of a single dose of a sustained release theophylline sprinkle formulation in children.
    Pedersen S; Steffensen G
    Allergy; 1986 Jan; 41(1):46-50. PubMed ID: 3963315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.